Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15091 | 0.90 | CA12 (0.52) | CA12CA2CA9CA1USP2 | |
| SCHEMBL26706541 | 0.89 | CA12 (0.41) | CA12CA2CA9CA1USP2 | |
| SCHEMBL23306872 | 0.87 | MAPT (0.50) | CA12CA2CA9CA1USP2 | |
| SCHEMBL19801499 | 0.87 | CA12 (0.44) | CA12CA2CA9CA1USP2 | |
| SCHEMBL23306871 | 0.87 | MAPT (0.50) | CA12CA2CA9CA1USP2 | |
| Water SCHEMBL2217898 | 0.87 | CA12 (0.50) | CA12CA2CA9CA1USP2 | |
| SCHEMBL3973874 | 0.87 | CA12 (0.56) | CA12CA2CA9CA1USP2 | |
| SCHEMBL12918862 | 0.87 | CA12 (0.56) | CA12CA2CA9CA1USP2 | |
| SCHEMBL31696969 | 0.87 | CA12 (0.50) | CA12CA2CA9CA1USP2 | |
| Hydrochloric Acid SCHEMBL473385 | 0.87 | CA12 (0.50) | CA12CA2CA9CA1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11801500-B2 | Methods for producing tertiary amine catalysts and uses of such | HUNTSMAN PETROCHEMICAL LLC (US) | 2023-10-31 | — | — | US | disclosed |
| US-11801500-B2 | Methods for producing tertiary amine catalysts and uses of such | HUNTSMAN PETROCHEMICAL LLC (US) | 2023-10-31 | — | — | US | disclosed |
| US-11801500-B2 | Methods for producing tertiary amine catalysts and uses of such | HUNTSMAN PETROCHEMICAL LLC (US) | 2023-10-31 | — | — | US | disclosed |
| US-20210121860-A1 | METHODS FOR PRODUCING TERTIARY AMINE CATALYSTS AND USES OF SUCH | HUNTSMAN PETROCHEMICAL LLC (US) | 2021-04-29 | — | — | US | disclosed |
| US-20210121860-A1 | METHODS FOR PRODUCING TERTIARY AMINE CATALYSTS AND USES OF SUCH | HUNTSMAN PETROCHEMICAL LLC (US) | 2021-04-29 | — | — | US | disclosed |
| EP-2646489-B1 | BLOWING CATALYST | HUNTSMAN CORP HUNGARY ZRT (HU) | 2018-07-04 | — | — | EP | disclosed |
| EP-2646489-B1 | BLOWING CATALYST | HUNTSMAN CORP HUNGARY ZRT (HU) | 2018-07-04 | — | — | EP | disclosed |
| US-9382397-B2 | Blowing catalyst | Huntsman Corporation Hungary ZRt (HU) | 2016-07-05 | — | — | US | disclosed |
| US-9382397-B2 | Blowing catalyst | Huntsman Corporation Hungary ZRt (HU) | 2016-07-05 | — | — | US | disclosed |
| US-9382397-B2 | Blowing catalyst | Huntsman Corporation Hungary ZRt (HU) | 2016-07-05 | — | — | US | disclosed |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN INTERNATIONAL LLC | 2012-05-24 | — | — | US | disclosed |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN INTERNATIONAL LLC | 2012-05-24 | — | — | US | disclosed |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | HUNTSMAN INTERNATIONAL LLC | 2012-05-24 | — | — | US | disclosed |
| EP-2438038-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | Huntsman Corporation Hungary ZRt. (HU) | 2012-04-11 | — | — | EP | disclosed |
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | Huntsman Corporation Hungary ZRt (HU) | 2012-03-22 | — | — | US | disclosed |
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | Huntsman Corporation Hungary ZRt (HU) | 2012-03-22 | — | — | US | disclosed |
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | Huntsman Corporation Hungary ZRt (HU) | 2012-03-22 | — | — | US | disclosed |
| WO-2010139520-A1 | A Method for Separating N,N-Dialkylbisaminoalkylether from Mixtures Comprising N,N-Dialkylbisaminoalkylether and at least one of N,N,N'-Trialkylbisaminoalkylether and N,N,N',N'-Tetraalkylbisaminoalkylether | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
| WO-2010139521-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
| WO-2010139521-A1 | A METHOD FOR PROVIDING A SECONDARY OR TERTIARY AMINE | HUNTSMAN CORPORATION HUNGARY ZRT. (HU) | 2010-12-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210121860-A1 | METHODS FOR PRODUCING TERTIARY AMINE CATALYSTS AND USES OF SUCH | PNMT, HNMT, TH | CA12 1464/4885CA2 3253/4885CA9 1254/4885 |
| US-20120071622-A1 | Method for Providing a Secondary or Tertiary Amine | HRH3, HRH4, NPR3 | CA12 2348/4885CA2 1997/4885CA9 1747/4885 |
| US-11801500-B2 | Methods for producing tertiary amine catalysts and uses of such | PNMT, HNMT, TH | CA12 1464/4885CA2 3253/4885CA9 1254/4885 |
| US-20120130132-A1 | METHOD FOR SEPARATING N,N-DIALKYLBISAMINOALKYLETHER FROM MIXTURES COMPRISING N,N-DIALKYLBISAMINOALKYLETHER AND AT LEAST ONE OF N,N,N'-TRIALKYLBISAMINOALKYLETHER AND N,N,N',N'-TETRAALKYLBISAMINOALKYLETHER | NCLN, NCL, DNPH1 | CA12 2473/4885CA2 3701/4885CA9 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.